![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SUN PHARMACEUTICAL INDUSTRIES Q4 FY 05-06 NET UP 38.17% TO RS 1428.5 MN
SUN PHARMACEUTICAL INDUSTRIES Q4 FY 05-06 NET UP 38.17% TO RS 1428.5 MN
Sun Pharma recorded the considerable increment of 46% in its (unaudited) net profit to Rs 1158.9 mn in Q4 FY 2005-06 compared to the same period of 2004-05. The total income(unaudited) grew by 32.79% to the Rs 4544.30 million in Q4 FY 2005-06.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct